Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.
Part of paid clinical trials in Milwaukee, Wisconsin.
- Sponsor
- Medical College of Wisconsin
- Study ID
- NCT06617949
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Substance Use Disorder (SUD)
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 40 Years
- Healthy Volunteers
- Not accepted
Interventions
- Regional Anesthesia — DRUGTransverse abdominal Plane(TAP) Block with long acting Exparel placed by a regional anesthesiologist.
- Hydromorphone Patient Controlled Analgelsic — DRUGThis group will be administered epidural PCA as a modality for pain control post cesarian section
- Epidural local anesthetic infusion — PROCEDUREEpidural group will receive pain control via a local anesthetic intermediate bolus infusion
Study Details
The purpose of this study is to investigate the efficacy of three different modalities of post-operative pain control in parturient with opioid use disorders. The investigators aim to determine whether the different approach utilized show better outcomes with pain management and if there are any association with reduction of symptoms of anxiety, depression, and overall well-being.
Key Dates
- Start date
- Jan 16, 2025
- Status verified
- Oct 2025
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Transverse abdominal Plane(TAP) Block with long acting ExparelA subset of participants (n=15) will be divided into three different arms: A.) Postoperative Epidural infusion for 24-36hrs B.) Hydromorphone Patient Controlled Analgesia (PCA) with Preservative free Morphine via epidural for 36hrs C.) Transverse abdominal Plane(TAP) Block with long acting Exparel.
- Active Comparator: Postoperative Epidural infusion for 24-36hrsA subset of participants (n=15) will be divided into three different arms: A.) Postoperative Epidural infusion for 24-36hrs B.) Hydromorphone Patient Controlled Analgesia (PCA) with Preservative free Morphine via epidural for 36hrs C.) Transverse abdominal Plane(TAP) Block with long acting Exparel.
- Active Comparator: Hydromorphone Patient Controlled Analgesia (PCA),Preservative free Morphine via epidural for 36hrsA subset of participants (n=15) will be divided into three different arms: A.) Postoperative Epidural infusion for 24-36hrs B.) Hydromorphone Patient Controlled Analgesia (PCA) with Preservative free Morphine via epidural for 36hrs C.) Transverse abdominal Plane(TAP) Block with long acting Exparel.
Primary Outcome Measure
Number of participants with Change in pain assessment scores from baseline post surgery [ Time Frame: immediately after the study intervention and up to post op day 2 ]
Central Contacts
- Meredith Albrecht, MD, PhD414-805-8700
- Christopher Fadumiye, MD414-805-8700
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Froedtert Hospital | Milwaukee | Wisconsin | 53226 | |
| Froedtert Hospital Milwaukee, Wisconsin 53226 | Milwaukee | Wisconsin | 53226 | Christopher Fadumiye |
Find similar trials in Milwaukee, WI
Related Studies
- Calls and Coordination for Transitions of Care at Re-entryRecruiting · University of Wisconsin, Madison · Madison, Wisconsin
- Open-Label Psilocybin Study in Transdiagnostic PopulationPHASE1 · Recruiting · Yale University · New Haven, Connecticut
- Expanding Access to mTBI Treatment for Veterans and Service Members With Co-occurring Substance UseNot Yet Recruiting · Shepherd Center, Atlanta GA · Atlanta, Georgia
- Trauma-informed Intervention to Reduce Substance Use and to Support Community TransitionEnrolling By Invitation · Michele Staton · Frankfort, Kentucky